Literature DB >> 17177138

Protective effect of Gui Qi mixture on the progression of diabetic nephropathy in rats.

Y-W Zhang1, D Xie, Y-X Chen, H-Y Zhang, Z-X Xia.   

Abstract

Huang Qi (root of Astragalus membranaceus) and Dang Gui ( Angelica sinensis), two of the most widely used herbs in traditional Chinese medicine, have been proven to be effective in the treatment of diabetes mellitus (DM) although the underlying molecular mechanisms are not fully elucidated. This study was designed to investigate the protective effect of Dang Gui and Huang Qi mixture (GQM) on the development of diabetic nephropathy in rats with streptozotocin (STZ)-induced DM and the possible underlying molecular mechanism. The diabetic animal model was made by a single intraperitoneal injection of STZ and then treated with GQM or benazepril. Blood glucose, triglyceride (TG), cholesterol (CHO), high density lipoprotein (HDL), serum creatinine (Scr), creatinine clearance rate (Ccr), blood urea nitrogen (BUN), urine beta (2)-microglobin (beta (2)-MG), kidney/body weight (K/B) ratio, glomerular area (GA), renal transforming growth factor-beta (1) (TGF-beta (1)) mRNA expression and blood and renal angiotensin II (AngII) expression were determined 8 weeks after the treatment. The blood glucose, CHO and TG levels, BUN, SCr, Ccr. K/B ratio, GA, the excretion of beta (2)-MG, renal TGF-beta (1) mRNA expression and blood and renal AngII expression were significantly increased while the HDL level was decreased 8 week after STZ injection. The changes in blood glucose, TG, CHO and HDL were reversed by GQM, not by benazepril, whereas the changes in other variables were reversed by both GQM and benazepril. Our results suggest that GQM alleviates the disorder in blood glucose and lipids, protects against the progression of renal nephropathy in diabetic rats, probably by inhibiting the expression of AngII and TGF-beta (1) mRNA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17177138     DOI: 10.1055/s-2006-948307

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  10 in total

Review 1.  The Latest Research Advances of Danggui Buxue Tang as an Effective Prescription for Various Diseases: A Comprehensive Review.

Authors:  Chen-Chen Ma; Yue-Hua Jiang; Yan Wang; Rui-Rong Xu
Journal:  Curr Med Sci       Date:  2022-10-17

2.  Na+,K+-ATPase is modulated by angiotensin II in diabetic rat kidney--another reason for diabetic nephropathy?

Authors:  Andrea Fekete; Klara Rosta; Laszlo Wagner; Agnes Prokai; Peter Degrell; Eva Ruzicska; Edit Vegh; Miklos Toth; Katalin Ronai; Krisztina Rusai; Aniko Somogyi; Tivadar Tulassay; Attila J Szabo; Agota Ver
Journal:  J Physiol       Date:  2008-09-25       Impact factor: 5.182

Review 3.  Chinese medicine for treating diabetic nephropathy.

Authors:  Bin Wang; Lan Lin; Qing Ni; Cheng-lian Su
Journal:  Chin J Integr Med       Date:  2013-03-26       Impact factor: 1.978

4.  Protective effects of Danggui Buxue Tang on renal function, renal glomerular mesangium and heparanase expression in rats with streptozotocin-induced diabetes mellitus.

Authors:  Tai-Sheng Ye; Ying-Wen Zhang; Xian-Mei Zhang
Journal:  Exp Ther Med       Date:  2016-04-01       Impact factor: 2.447

5.  Astragaloside IV synergizes with ferulic acid to inhibit renal tubulointerstitial fibrosis in rats with obstructive nephropathy.

Authors:  L Q Meng; J W Tang; Y Wang; J R Zhao; M Y Shang; M Zhang; S Y Liu; L Qu; S Q Cai; X M Li
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

6.  Role of Bone Morphogenetic Proteins-7 (BMP-7) in the Renal Improvement Effect of DangGui (Angelica sinensis) in Type-1 Diabetic Rats.

Authors:  Ching-Hua Yeh; Chen-Kuei Chang; Kai-Chun Cheng; Ying-Xiao Li; Ying Wen Zhang; Juei-Tang Cheng
Journal:  Evid Based Complement Alternat Med       Date:  2011-08-22       Impact factor: 2.629

7.  Chinese medicines in the treatment of experimental diabetic nephropathy.

Authors:  Jing-Yi Liu; Xiao-Xin Chen; Sydney Chi-Wai Tang; Stephen Cho-Wing Sze; Yi-Bin Feng; Kai-Fai Lee; Kalin Yan-Bo Zhang
Journal:  Chin Med       Date:  2016-02-24       Impact factor: 5.455

8.  Danggui Buxue Tang Attenuates Tubulointerstitial Fibrosis via Suppressing NLRP3 Inflammasome in a Rat Model of Unilateral Ureteral Obstruction.

Authors:  Linna Wang; Jiwei Ma; Cunxia Guo; Changyong Chen; Zhong Yin; Xueguang Zhang; Xiangmei Chen
Journal:  Biomed Res Int       Date:  2016-10-31       Impact factor: 3.411

9.  Angelica sinensis (Oliv.) Diels: Influence of Value Chain on Quality Criteria and Marker Compounds Ferulic Acid and Z-Ligustilide.

Authors:  Nino Giacomelli; Yang Yongping; Franz K Huber; Anita Ankli; Caroline S Weckerle
Journal:  Medicines (Basel)       Date:  2017-03-14

10.  Danggui buxue tang inhibited mesangial cell proliferation and extracellular matrix accumulation through GAS5/NF-κB pathway.

Authors:  Rui Zhang; Xiao Han; Tao Huang; Xiuge Wang
Journal:  Biosci Rep       Date:  2019-10-30       Impact factor: 3.840

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.